Page last updated: 2024-10-31

mianserin and Essential Tremor

mianserin has been researched along with Essential Tremor in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Essential Tremor: A relatively common disorder characterized by a fairly specific pattern of tremors which are most prominent in the upper extremities and neck, inducing titubations of the head. The tremor is usually mild, but when severe may be disabling. An autosomal dominant pattern of inheritance may occur in some families (i.e., familial tremor). (Mov Disord 1988;13(1):5-10)

Research Excerpts

ExcerptRelevanceReference
"We sought to determine whether mirtazapine is safe and well-tolerated as a treatment for essential tremor (ET)."9.10Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study. ( Lyons, KE; Pahwa, R, 2003)
"We sought to determine whether mirtazapine is safe and well-tolerated as a treatment for essential tremor (ET)."5.10Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study. ( Lyons, KE; Pahwa, R, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pahwa, R1
Lyons, KE1

Trials

1 trial available for mianserin and Essential Tremor

ArticleYear
Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study.
    Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:5

    Topics: Aged; Antidepressive Agents, Tricyclic; Cross-Over Studies; Double-Blind Method; Essential Tremor; F

2003